Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a… Grant US-11723951-B2 United States of America 15 Aug 2023
Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a… Grant US-10722551-B2 United States of America 28 Jul 2020
Fusion proteins comprising P3 of bacteriophage Grant US-10526377-B2 United States of America 07 Jan 2020
DIPEPTIDE-REPEAT PROTEINS AS THERAPEUTIC TARGET IN NEURODEGENERATIVE DISEASES WITH… Application EP-3588091-A1 European Patent Office 01 Jan 2020
Fusion proteins comprising P3 of bacteriophage Grant US-10208090-B2 United States of America 19 Feb 2019
Bacteriophage gene 3 protein compositions and use as amyloid binding agents Grant US-10151762-B2 United States of America 11 Dec 2018
Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced… Grant US-9988444-B2 United States of America 05 Jun 2018
Bacteriophage gene 3 protein compositions and use as amyloid binding agents Grant US-9688728-B2 United States of America 27 Jun 2017
Bacteriophage gene 3 protein compositions and use as amyloid binding agents Grant US-9493516-B2 United States of America 15 Nov 2016
Bacteriophage gene 3 protein compositions and use as amyloid binding agents Grant US-9493515-B2 United States of America 15 Nov 2016
DIPEPTIDE-REPEAT PROTEINS AS THERAPEUTIC TARGET IN NEURODEGENERATIVE DISEASES WITH… Application WO-2014114660-A1 World Intellectual Property Organisation (WIPO) 31 Jul 2014
DIPEPTIDE-REPEAT PROTEINS AS THERAPEUTIC TARGET IN NEURODEGENERATIVE DISEASES WITH… Application WO-2014114303-A1 World Intellectual Property Organisation (WIPO) 31 Jul 2014